Although EGFR mutations are rare in AML (9–11), the level of EGF—the main EGFR ligand—was elevated in the urine of patients diagnosed with APL and decreased after ATRA-induced complete remission (12). This evidence concerns the gene EGFR and acute myeloid leukemia.